Primary record
(S)-2-(2-(5-(5-carbamimidoyl-1H-benzo[d]imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-[1,1'-biphenyl]-3-yl)acetamido)succinic aciduinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
- 库存
- 8,063 克
- 纯度
- 99.7 %
- CAS
- 871266-63-6
化合物标识与属性
- CAS
- 871266-63-6
- PubChem CID
- 135425273
- SMILES
- C1=CC2=C(C=C1C(=N)N)NC(=N2)C3=CC(=CC(=C3O)C4=C(C=CC(=C4)S(=O)(=O)N)O)CC(=O)N[C@@H](CC(=O)O)C(=O)O
- Canonical SMILES
- N=C(N)c1ccc2nc(-c3cc(CC(=O)N[C@@H](CC(=O)O)C(=O)O)cc(-c4cc(S(N)(=O)=O)ccc4O)c3O)[nH]c2c1
名称与同义词
- PCI-27483
- 871266-63-6
- A1IOK
- RefChem:170500
- UNII-6073LCU8U9
- 6073LCU8U9
- PCI27483
- MFCD25976837
- orb1695177
- SCHEMBL1303963
- CHEMBL4297315
- CRA-027483
- SCHEMBL29376839
- C26H24N6O9S
- GTPL11585
- PCI 27483
- PVTVTDSZGJFYRP-LIAPLOTISA-N
- WDJHHCAKBRKCLW-IBGZPJMESA-N
- GLXC-90209
- AOB87178
- BCP21044
- Factor VIIa Inhibitor PCI-27483
- NSC782579
- ZINC43100782
- AKOS030627138
- AKOS032960310
- ZINC136621884
- CS-6692
- DB13000
- NSC-782579
- PCI-27483?
- CID11614097
- Example 1 [WO2005118554A2]
- AC-36014
- AS-17004
- CID 11614097
- DA-56628
- FP137708
- HY-16382
- PCI27483; PCI 27483
- FT-0700496
- NS00072494
- A14368
- Z-3280
- (S)-2-(2-(5-(5-Carbamimidoyl-1H-benzo(d)imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-(1,1'-biphenyl)-3-yl)acetamido)succinic acid
- A1205456
- Q27263177
- L-Aspartic acid, N-(2-(5-(6-(aminoiminomethyl)-1H-benzimidazol-2-yl)-5'-(aminosulfonyl)-2',6-dihydroxy(1,1'-biphenyl)-3-yl)acetyl)-
- (2-(5-(6-carbamimidoyl-1H-benzo[d]imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-[1,1'-biphenyl]-3-yl)acetyl)-L-aspartic acid
- (2S)-2-[[2-[3-(6-carbamimidoyl-1H-benzimidazol-2-yl)-4-hydroxy-5-(2-hydroxy-5-sulfamoylphenyl)phenyl]acetyl]amino]butanedioic acid
- (S)-2-(2-(5-(5-carbamimidoyl-1H-benzo[d]imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-[1,1'-biphenyl]-3-yl)acetamido)succinic acid.
- (S)-2-(2-(5-(5-Carbamimidoyl-1H-benzo[d]imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoylbiphenyl-3-yl)acetamido)succinic acid
- N-((5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-3-biphenylyl)acetyl)-L-aspartic acid
- (2S)-2-(2-(5-(6-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-(1,1'-biphenyl)-3-yl)acetamido)butanedioic acid
- (2S)-2-[[2-[3-(6-carbamimidoyl-1H-benzimidazol-2-yl)-4-hydroxy-5-(2-hydroxy-5-sulfamoyl-phenyl)phenyl]acetyl]amino]butanedioic acid
- (2S)-2-{2-[3-(6-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(2-hydroxy-5-sulfamoylphenyl)phenyl]acetamido}butanedioic acid
- (S)-2-(2-(5-(5-carbamimidoyl-1H-benzo[d]imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-[1,1'-biphenyl]-3-yl)acetamido)succinic aciduinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
- (S)-2-{2-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-6,2'-dihydroxy-5'-sulfamoylbiphenyl-3-yl]acetylamino}succinic acid
- 2-[[2-[(3E)-3-(5-carbamimidoyl-1,3-dihydrobenzimidazol-2-ylidene)-5-(2-hydroxy-5-sulfamoylphenyl)-4-oxocyclohexa-1,5-dien-1-yl]acetyl]amino]butanedioic acid
- 2-{2-[5-(5-carbamimidoyl-1h-benzoimidazol-2-yl)-6,2'-dihydroxy-5'-sulfamoyl-biphenyl-3-yl]-acetylamino}-succinic acid
- L-aspartic acid, N-(2-(5(6-(aminoiminomethyl)-1H-benzimidazol-2-yl)-5'-(aminosulfonyl)-2',6-dihydroxy(1,1'-biphenyl)-3-yl)acetyl)-